Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bayer Aktienges ADR (BAYRY)

Bayer Aktienges ADR (BAYRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bayer Aktienges ADR Kaiser-Wilhelm-Allee 1 Leverkusen 2M 51368 DEU

www.bayer.com Employees: 99,723 P: 49-21-4-30-1

Description:

Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.

Key Statistics

Overview:

Market Capitalization, $K 19,294,826
Enterprise Value, $K 61,611,676
Shares Outstanding, K 3,929,700
Annual Sales, $ 51,558 M
Annual Net Income, $ -3,183 M
Last Quarter Sales, $ 10,961 M
Last Quarter Net Income, $ -4,600 M
EBIT, $ 550,070 K
EBITDA, $ 11,395 M
60-Month Beta 1.03
% of Institutional Shareholders 0.00%
Float, K 0
% Float 0.00%
Short Volume Ratio 0.08

Growth:

1-Year Return -44.20%
3-Year Return -62.69%
5-Year Return -76.01%
5-Year Revenue Growth 10.28%
5-Year Earnings Growth -1.14%
5-Year Dividend Growth -21.05%

Per-Share Information:

Most Recent Earnings 0.07 on 11/12/24
Next Earnings Date 11/13/24
Earnings Per Share ttm 1.59
EPS Growth vs. Prev Qtr -72.00%
EPS Growth vs. Prev Year -30.00%
Annual Dividend Rate, $ 0.02
Annual Dividend Yield 0.45%
Most Recent Dividend 0.022 on 04/29/24
Next Ex-Dividends Date 04/29/24
Dividend Payable Date 05/13/24
Dividend Payout Ratio 0.00%
Most Recent Split 4-1 on 09/20/17

BAYRY Ratios

Ratio
Price/Earnings ttm 3.10
Price/Earnings forward 3.75
Price/Earnings to Growth N/A
Return-on-Equity % 16.90%
Return-on-Assets % 4.94%
Profit Margin % -6.17%
Debt/Equity 1.34
Price/Sales 0.38
Price/Cash Flow 1.28
Price/Book 0.47
Book Value/Share 0.00
Interest Coverage -0.39

BAYRY Dividends

Date Value
04/29/24 $0.0220
05/02/23 $0.4510
05/02/22 $0.3520
04/28/21 $0.4150
04/29/20 $0.5310
04/29/19 $0.5460
05/25/18 $0.5690
05/01/17 $2.1570
04/27/16 $2.0910
05/22/15 $1.8590
04/25/14 $2.1110
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar